Predictors of complete pathologic response (pT0) to neoadjuvant chemotherapy in muscle-invasive bladder carcinoma

VK Pokuri, JR Syed, Z Yang, EP Field, S Cyriac… - Clinical genitourinary …, 2016 - Elsevier
Background Randomized trials have supported the use of cisplatin-based neoadjuvant
chemotherapy (NAC) in muscle-invasive bladder carcinoma (MIBC) owing to the survival …
被引用次数：61 相关文章

Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma.

VK Pokuri, JR Syed, Z Yang, EP Field… - Clinical Genitourinary …, 2015 - europepmc.org
Background Randomized trials have supported the use of cisplatin-based neoadjuvant
chemotherapy (NAC) in muscle-invasive bladder carcinoma (MIBC) owing to the survival …

Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma

VK Pokuri, JR Syed, Z Yang, EP Field… - Clinical …, 2016 - pure.johnshopkins.edu
Background Randomized trials have supported the use of cisplatin-based neoadjuvant
chemotherapy (NAC) in muscle-invasive bladder carcinoma (MIBC) owing to the survival …

Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma

VK Pokuri, JR Syed, Z Yang… - Clinical …, 2016 - pubmed.ncbi.nlm.nih.gov
No predictors of a complete pathologic response (pT0) to neoadjuvant chemotherapy (NAC)
in muscle-invasive bladder carcinoma have been established. We performed a retrospective …

Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma

VK Pokuri, JR Syed, Z Yang, EP Field, S Cyriac… - Clinical Genitourinary …, 2016 - infona.pl
Randomized trials have supported the use of cisplatin-based neoadjuvant chemotherapy
(NAC) in muscle-invasive bladder carcinoma (MIBC) owing to the survival advantage, which …

Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma

VK Pokuri, JR Syed, Z Yang… - Clinical …, 2016 - clinical-genitourinary-cancer.com
Background Randomized trials have supported the use of cisplatin-based neoadjuvant
chemotherapy (NAC) in muscle-invasive bladder carcinoma (MIBC) owing to the survival …